{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T08:04:52Z","timestamp":1784189092818,"version":"3.55.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T00:00:00Z","timestamp":1779494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T00:00:00Z","timestamp":1784160000000},"content-version":"vor","delay-in-days":54,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100007449","name":"Takeda Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007449","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008731","name":"Nakatomi Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["24K12303"],"award-info":[{"award-number":["24K12303"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["24K12303"],"award-info":[{"award-number":["24K12303"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["24K12303"],"award-info":[{"award-number":["24K12303"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011649","name":"Japan Orthopaedics and Traumatology Foundation","doi-asserted-by":"publisher","award":["Grant No. 637"],"award-info":[{"award-number":["Grant No. 637"]}],"id":[{"id":"10.13039\/501100011649","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Discov."],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Dupuytren\u2019s contracture is a superficial fibrotic disease of the hands that causes flexion contractures of the affected fingers. Diabetes mellitus (DM) is a risk factor for Dupuytren\u2019s contracture. However, the exact underlying mechanisms by which DM is involved in its development and progression remain unknown. This study investigated the involvement of glycometabolic disorders in the pathogenesis of Dupuytren\u2019s contracture. RNA sequencing revealed that S100A4 expression was significantly increased in Dupuytren\u2019s contracture-derived fibroblasts under high-glucose conditions compared with low-glucose conditions, and this finding was confirmed by immunoblotting and enzyme-linked immunosorbent assay.\n                    <jats:italic>S100A4<\/jats:italic>\n                    expression in Dupuytren\u2019s contracture tissues was significantly higher in patients with diabetes than in those without. S100A4 was expressed in several cell types, including fibroblasts, myofibroblasts, and macrophages. However, the expression of its receptor, Toll-like receptor 4 (TLR4), was predominantly detected in CD68-expressing macrophages. Furthermore, recombinant S100A4 treatment significantly increased transforming growth factor-beta 1 (TGF-\u03b21) expression, which is a central mediator of fibrosis, in macrophages. Pharmacological inhibition of TLR4 suppresses TGF-\u03b21 upregulation via S100A4. Thus, the S100A4\u2013TLR4\u2013TGF-\u03b2 axis could be a potential therapeutic target for Dupuytren\u2019s contracture in diabetic patients.\n                  <\/jats:p>","DOI":"10.1038\/s41420-026-03167-y","type":"journal-article","created":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T02:35:53Z","timestamp":1779503753000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["S100A4\u2013TLR4\u2013TGF-\u03b2 axis as a therapeutic target for Dupuytren\u2019s contracture in diabetic patients"],"prefix":"10.1038","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0984-933X","authenticated-orcid":false,"given":"Koki","family":"Kato","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7639-7484","authenticated-orcid":false,"given":"Shingo","family":"Komura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuta","family":"Yanagihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noritaka","family":"Saeki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Goto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rie","family":"Maki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitoshi","family":"Hirose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiro","family":"Hirakawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuuki","family":"Imai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruhiko","family":"Akiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,23]]},"reference":[{"key":"3167_CR1","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.molmed.2022.12.001","volume":"29","author":"TB Layton","year":"2023","unstructured":"Layton TB, Williams L, Nanchahal J. Dupuytren\u2019s disease: a localised and accessible human fibrotic disorder. Trends Mol Med. 2023;29:218\u201327.","journal-title":"Trends Mol Med"},{"key":"3167_CR2","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1177\/1558944718787281","volume":"15","author":"L Carr","year":"2020","unstructured":"Carr L, Michelotti B, Brgoch M, Hauck R, Ingraham J. Dupuytren disease management trends: a survey of hand surgeons. Hand. 2020;15:97\u2013102.","journal-title":"Hand"},{"key":"3167_CR3","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s12570-012-0092-z","volume":"3","author":"C Bainbridge","year":"2012","unstructured":"Bainbridge C, Dahlin LB, Szczypa PP, Cappelleri JC, Gu\u00e9rin D, Gerber RA. Current trends in the surgical management of Dupuytren\u2019s disease in Europe: an analysis of patient charts. Eur Orthop Traumatol. 2012;3:31\u201341.","journal-title":"Eur Orthop Traumatol"},{"key":"3167_CR4","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/s43856-023-00332-7","volume":"3","author":"S Ganesan","year":"2023","unstructured":"Ganesan S, Tantone RP, Komatsu DE, Hurst LC. The prevalence of Dupuytren\u2019s disease in patients with diabetes mellitus. Commun Med. 2023;3:96.","journal-title":"Commun Med"},{"key":"3167_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-94025-7","volume":"11","author":"M Rydberg","year":"2021","unstructured":"Rydberg M, Zimmerman M, L\u00f6fgren JP, Gotts\u00e4ter A, Nilsson PM, Melander O, et al. Metabolic factors and the risk of Dupuytren\u2019s disease: data from 30,000 individuals followed for over 20 years. Sci Rep. 2021;11:14669.","journal-title":"Sci Rep"},{"key":"3167_CR6","first-page":"373","volume":"19","author":"D Kovacs","year":"2012","unstructured":"Kovacs D, Demian L, Babes A. Prevalence and risk of Dupuytr\u00e8n disease in patients with diabetes versus non-diabetic patients. Rom J Diab Nutr Metab Dis. 2012;19:373\u201380.","journal-title":"Rom J Diab Nutr Metab Dis"},{"key":"3167_CR7","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/s13018-018-0848-4","volume":"13","author":"F Takase","year":"2018","unstructured":"Takase F, Mifune Y, Inui A, Ueda Y, Kataoka T, Kokubu T, et al. Association of advanced glycation end products in Dupuytren disease. J Orthop Surg Res. 2018;13:143.","journal-title":"J Orthop Surg Res"},{"key":"3167_CR8","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.matbio.2010.04.004","volume":"29","author":"A Yuen","year":"2010","unstructured":"Yuen A, Laschinger C, Talior I, Lee W, Chan M, Birek J, et al. Methylglyoxal-modified collagen promotes myofibroblast differentiation. Matrix Biol. 2010;29:537\u201348.","journal-title":"Matrix Biol"},{"key":"3167_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.matbio.2024.01.002","volume":"127","author":"S O\u2019Reilly","year":"2024","unstructured":"O\u2019Reilly S. S100A4 a classical DAMP as a therapeutic target in fibrosis. Matrix Biol. 2024;127:1\u20137.","journal-title":"Matrix Biol"},{"key":"3167_CR10","first-page":"1391","volume":"38","author":"BM Fendt","year":"2023","unstructured":"Fendt BM, Hirschmann A, Bruns M, Camarillo-Retamosa E, Ospelt C, Vogetseder A. Protein atlas of fibroblast specific protein 1 (FSP1)\/S100A4. Histol Histopathol. 2023;38:1391\u2013401.","journal-title":"Histol Histopathol"},{"key":"3167_CR11","doi-asserted-by":"publisher","first-page":"5973","DOI":"10.1111\/jcmm.15259","volume":"24","author":"Z Li","year":"2020","unstructured":"Li Z, Li Y, Liu S, Qin Z. Extracellular S100A4 as a key player in fibrotic diseases. J Cell Mol Med. 2020;24:5973\u201383.","journal-title":"J Cell Mol Med"},{"key":"3167_CR12","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1136\/annrheumdis-2013-204516","volume":"74","author":"M Tomcik","year":"2015","unstructured":"Tomcik M, Palumbo-Zerr K, Zerr P, Avouac J, Dees C, Sumova B, et al. S100A4 amplifies TGF-\u03b2-induced fibroblast activation in systemic sclerosis. Ann Rheum Dis. 2015;74:1748\u201355.","journal-title":"Ann Rheum Dis"},{"key":"3167_CR13","doi-asserted-by":"publisher","first-page":"2901","DOI":"10.1002\/art.22042","volume":"54","author":"RR Yammani","year":"2006","unstructured":"Yammani RR, Carlson CS, Bresnick AR, Loeser RF. Increase in production of matrix metalloproteinase 13 by human articular chondrocytes due to stimulation with S100A4: role of the receptor for advanced glycation end products. Arthritis Rheum. 2006;54:2901\u201311.","journal-title":"Arthritis Rheum"},{"key":"3167_CR14","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1093\/rheumatology\/keu031","volume":"53","author":"LA Cerezo","year":"2014","unstructured":"Cerezo LA, Rem\u00e1kov\u00e1 M, Tom\u010dik M, Gay S, Neidhart M, Lukanidin E, et al. The metastasis-associated protein S100A4 promotes the inflammatory response of mononuclear cells via the TLR4 signalling pathway in rheumatoid arthritis. Rheumatology. 2014;53:1520\u20136.","journal-title":"Rheumatology"},{"key":"3167_CR15","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1038\/s42003-023-05558-8","volume":"6","author":"A Goto","year":"2023","unstructured":"Goto A, Komura S, Kato K, Maki R, Hirakawa A, Tomita H, et al. C-X-C domain ligand 14-mediated stromal cell-macrophage interaction as a therapeutic target for hand dermal fibrosis. Commun Biol. 2023;6:1173.","journal-title":"Commun Biol"},{"key":"3167_CR16","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aay0370","volume":"5","author":"D Izadi","year":"2019","unstructured":"Izadi D, Layton TB, Williams L, McCann F, Cabrita M, Espirito Santo AI, et al. Identification of TNFR2 and IL-33 as therapeutic targets in localized fibrosis. Sci Adv. 2019;5:eaay0370.","journal-title":"Sci Adv"},{"key":"3167_CR17","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aaz8272","volume":"6","author":"M Akbar","year":"2020","unstructured":"Akbar M, Garcia-Melchor E, Chilaka S, Little KJ, Sood S, Reilly JH, et al. Attenuation of Dupuytren\u2019s fibrosis via targeting of the STAT1 modulated IL-13R\u03b11 response. Sci Adv. 2020;6:eaaz8272.","journal-title":"Sci Adv"},{"key":"3167_CR18","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1093\/intimm\/dxad004","volume":"35","author":"H Kida","year":"2023","unstructured":"Kida H, Jiang JJ, Matsui Y, Takahashi I, Hasebe R, Kawamura D, et al. Dupuytren\u2019s contracture-associated SNPs increase SFRP4 expression in non-immune cells including fibroblasts to enhance inflammation development. Int Immunol. 2023;35:303\u201312.","journal-title":"Int Immunol"},{"key":"3167_CR19","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2120336119","volume":"119","author":"TB Layton","year":"2022","unstructured":"Layton TB, Williams L, Yang N, Zhang M, Lee C, Feldmann M, et al. A vasculature niche orchestrates stromal cell phenotype through PDGF signaling: importance in human fibrotic disease. Proc Natl Acad Sci USA 2022;119:e2120336119.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3167_CR20","doi-asserted-by":"publisher","first-page":"20753","DOI":"10.1073\/pnas.2004281117","volume":"117","author":"LM Williams","year":"2020","unstructured":"Williams LM, McCann FE, Cabrita MA, Layton T, Cribbs A, Knezevic B, et al. Identifying collagen VI as a target of fibrotic diseases regulated by CREBBP\/EP300. Proc Natl Acad Sci USA 2020;117:20753\u201363.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3167_CR21","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.jid.2021.05.030","volume":"142","author":"R Dobie","year":"2022","unstructured":"Dobie R, West CC, Henderson BEP, Wilson-Kanamori JR, Markose D, Kitto LJ, et al. Deciphering mesenchymal drivers of human Dupuytren\u2019s Disease at single-cell level. J Invest Dermatol. 2022;142:114\u2013123.e118.","journal-title":"J Invest Dermatol"},{"key":"3167_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-16158-7","volume":"12","author":"A Hillsley","year":"2022","unstructured":"Hillsley A, Santoso MS, Engels SM, Halwachs KN, Contreras LM, Rosales AM. A strategy to quantify myofibroblast activation on a continuous spectrum. Sci Rep. 2022;12:12239.","journal-title":"Sci Rep"},{"key":"3167_CR23","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.it.2009.12.001","volume":"31","author":"G Wick","year":"2010","unstructured":"Wick G, Backovic A, Rabensteiner E, Plank N, Schwentner C, Sgonc R. The immunology of fibrosis: innate and adaptive responses. Trends Immunol. 2010;31:110\u20139.","journal-title":"Trends Immunol"},{"key":"3167_CR24","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.immuni.2016.02.015","volume":"44","author":"TA Wynn","year":"2016","unstructured":"Wynn TA, Vannella KM. Macrophages in tissue repair, regeneration, and fibrosis. Immunity. 2016;44:450\u201362.","journal-title":"Immunity"},{"key":"3167_CR25","doi-asserted-by":"publisher","DOI":"10.1155\/2010\/672395","volume":"2010","author":"AM Piccinini","year":"2010","unstructured":"Piccinini AM, Midwood KS. DAMPening inflammation by modulating TLR signalling. Mediators Inflamm. 2010;2010:672395.","journal-title":"Mediators Inflamm"},{"key":"3167_CR26","doi-asserted-by":"publisher","first-page":"388","DOI":"10.3389\/fimmu.2018.00388","volume":"9","author":"Q Li","year":"2018","unstructured":"Li Q, Dai C, Xue R, Wang P, Chen L, Han Y, et al. S100A4 protects myeloid-derived suppressor cells from intrinsic apoptosis. Front Immunol. 2018;9:388.","journal-title":"Front Immunol"},{"key":"3167_CR27","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1002\/1878-0261.12319","volume":"12","author":"L Prasmickaite","year":"2018","unstructured":"Prasmickaite L, Tenstad EM, Pettersen S, Jabeen S, Egeland EV, Nord S, et al. Basal-like breast cancer engages tumor-supportive macrophages via secreted factors induced by extracellular S100A4. Mol Oncol. 2018;12:1540\u201358.","journal-title":"Mol Oncol"},{"key":"3167_CR28","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20190103","volume":"217","author":"N Frangogiannis","year":"2020","unstructured":"Frangogiannis N. Transforming growth factor-\u03b2 in tissue fibrosis. J Exp Med. 2020;217:e20190103.","journal-title":"J Exp Med"},{"key":"3167_CR29","doi-asserted-by":"publisher","first-page":"E928","DOI":"10.1073\/pnas.1301100110","volume":"110","author":"LS Verjee","year":"2013","unstructured":"Verjee LS, Verhoekx JS, Chan JK, Krausgruber T, Nicolaidou V, Izadi D, et al. Unraveling the signaling pathways promoting fibrosis in Dupuytren\u2019s disease reveals TNF as a therapeutic target. Proc Natl Acad Sci USA 2013;110:E928\u201337.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3167_CR30","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.jdermsci.2013.10.009","volume":"73","author":"H Suga","year":"2014","unstructured":"Suga H, Sugaya M, Fujita H, Asano Y, Tada Y, Kadono T, et al. TLR4, rather than TLR2, regulates wound healing through TGF-\u03b2 and CCL5 expression. J Dermatol Sci. 2014;73:117\u201324.","journal-title":"J Dermatol Sci"},{"key":"3167_CR31","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1038\/nm1663","volume":"13","author":"E Seki","year":"2007","unstructured":"Seki E, De Minicis S, Osterreicher CH, Kluwe J, Osawa Y, Brenner DA, et al. TLR4 enhances TGF-beta signaling and hepatic fibrosis. Nat Med. 2007;13:1324\u201332.","journal-title":"Nat Med"},{"key":"3167_CR32","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1038\/s41366-018-0018-0","volume":"42","author":"P Arner","year":"2018","unstructured":"Arner P, Petrus P, Esteve D, Boulomi\u00e9 A, N\u00e4slund E, Thorell A, et al. Screening of potential adipokines identifies S100A4 as a marker of pernicious adipose tissue and insulin resistance. Int J Obes. 2018;42:2047\u201356.","journal-title":"Int J Obes"},{"key":"3167_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2020.154187","volume":"105","author":"A Anguita-Ruiz","year":"2020","unstructured":"Anguita-Ruiz A, Mendez-Gutierrez A, Ruperez AI, Leis R, Bueno G, Gil-Campos M, et al. The protein S100A4 as a novel marker of insulin resistance in prepubertal and pubertal children with obesity. Metabolism. 2020;105:154187.","journal-title":"Metabolism"},{"key":"3167_CR34","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1111\/j.1749-6632.2011.06320.x","volume":"1243","author":"R Ramasamy","year":"2011","unstructured":"Ramasamy R, Yan SF, Schmidt AM. Receptor for AGE (RAGE): signaling mechanisms in the pathogenesis of diabetes and its complications. Ann N Y Acad Sci. 2011;1243:88\u2013102.","journal-title":"Ann N Y Acad Sci"},{"key":"3167_CR35","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/s13075-015-0661-y","volume":"17","author":"J Viil","year":"2015","unstructured":"Viil J, Maasalu K, M\u00e4emets-Allas K, Tamming L, L\u00f5hmussaar K, Tooming M, et al. Laminin-rich blood vessels display activated growth factor signaling and act as the proliferation centers in Dupuytren\u2019s contracture. Arthritis Res Ther. 2015;17:144.","journal-title":"Arthritis Res Ther"},{"key":"3167_CR36","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.3390\/ijms24021081","volume":"24","author":"CG C\u00e1rdenas-Le\u00f3n","year":"2023","unstructured":"C\u00e1rdenas-Le\u00f3n CG, M\u00e4emets-Allas K, Klaas M, Maasalu K, Jaks V. Proteomic analysis of dupuytren\u2019s contracture-derived sweat glands revealed the synthesis of connective tissue growth factor and initiation of epithelial-mesenchymal transition as major pathogenetic events. Int J Mol Sci. 2023;24:1081.","journal-title":"Int J Mol Sci"},{"key":"3167_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2023.105530","volume":"300","author":"BD Southern","year":"2024","unstructured":"Southern BD, Li H, Mao H, Crish JF, Grove LM, Scheraga RG, et al. A novel mechanoeffector role of fibroblast S100A4 in myofibroblast transdifferentiation and fibrosis. J Biol Chem. 2024;300:105530.","journal-title":"J Biol Chem"}],"container-title":["Cell Death Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41420-026-03167-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41420-026-03167-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41420-026-03167-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T07:14:55Z","timestamp":1784186095000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41420-026-03167-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,23]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3167"],"URL":"https:\/\/doi.org\/10.1038\/s41420-026-03167-y","relation":{},"ISSN":["2058-7716"],"issn-type":[{"value":"2058-7716","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,23]]},"assertion":[{"value":"1 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"310"}}